Whole Human Genome Oligo Microarray Analysis of the Peripheral Blood Mononuclear Cells of Patients With Rheumatoid Arthritis During Different Forms of Anti-Tumor Necrosis-Alpha Treatments.
Only patients who - regardless of this study - are scheduled and permitted to receive
anti-TNF-alpha treatment because of their RA will be asked to participate. No patient will
be recruited only for the sake of the study. The prescribing physicians will not be
influenced by the study as to what form of anti-TNF-alpha therapy they should select.
Time Perspective: Prospective
Gene expression (under- or overexpression) in the peripheral blood mononuclear cells
Weeks 0, 4, and 14.
Hungary: Not Applicable